Replies to post #15244 on Amarin Corp Plc (AMRN)

[Ajax133]

KCSVEN" Great response. Meaningful and makes a lot of sense.
The only purpose of my recent postings is to encourage this
type of enlightening dialogue. It is extremely productive,
and cuts to the chase.

[alternatepatel]

why they need to prove they can sell >bn$ a year?
They have a ++superior product compared to a bn$ product (Lovaza). That's enough to make even a dumb believe Vascepa can sell bn$ a year.

Profitability....
Why PCYC has a MCap of >10bn$ ? They are at-least 6 months away from approval and probably 9 months away from launch of first product and probably few year(s) away from profitability. If one can answer that, AMRN doesn't need to show profitability to WS for a 5-6bn MCap valuation.

Bottomline
AMRN is drastically undervalued. Can't say it any better.

[yellow_bluff]

agreed. we are here clamoring that the stock should be higher, but science aside, if you look at the numbers, you have a small drug co w huge cash burn who already had a $1B mkt cap, doing a GIA and numbers have to keep coming down while cash raises and other financings continue at a steady pace.

while we all believe in anchor, etc, one could make a decent case that it is not wildly undervalued unless you think anchor sells itself in six months...